QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
LON:XEN

804912 (XEN.L) (XEN) Share Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
539,436 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About 804912 (XEN.L)

Xenetic Biosciences plc, formerly Lipoxen plc, is a holding company engaged in development of drug and vaccine delivery systems and products in fields of protein drugs, vaccines and oncology. The Company’s technology platforms include PolyXen for extending efficacy and half life of biologic drugs; ImuXen for creating new vaccines and improving existing vaccines, and OncoHist for novel mode of action drugs for oncology therapies. It has drug and vaccine programs with three products in human clinical development, such as ErepoXen, which is a long-acting formulation for treatment of anaemia in both End Stage Renal Disease patients and for those undergoing chemotherapy; OncoHist, which is a recombinant human histone H1.3 molecule in Phase I clinical trials in Russia for refractory Acute Myeloid Leukaemia and Non Hodgkin's Lymphoma, and SuliXen, which is insulin for both treatment of diabetes and for central nervous system condition. On January 17, 2012, the Company acquired SymbioTec GmbH.

XEN Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive XEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 804912 (XEN.L) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

XEN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of 804912 (XEN.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 804912 (XEN.L) investors own include Widecells Group (WDC) and Ortac Resources (OTC).

How do I buy shares of 804912 (XEN.L)?

Shares of XEN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:XEN) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners